Journal of Community Medicine & Health Education
Open Access

Steven D. Weitman

The University of Texas Health Science Center at San Antonio, Cancer Therapy & Research Center, Institute for Drug Development, San Antonio, Texas 78229, USA

Biography

Steve obtained his M.D. and Ph.D. at the Medical College of Wisconsin. He is a Pediatric Hematology/Oncologist with about 25 years of experience in cancer drug development. Steve is currently Professor at the Institute for Drug Development at UT Health San Antonio.  He was previously Chief Medical Officer, Senior Vice President, and Member of the Executive Committee at ILEX Oncology where he led ILEX’s successful development of clofarabine (Clolar™) and guided that product through a successful ODAC and FDA approval.

Publications

Early Phase Clinical Trials: Referral Barriers and Promoters among Physicians

Background: Physician referral is among the most effective means of recruiting patients into cancer clinical trials. Therefore, to increase minority representation in early-phase clinical trials (EPCTs), specifically accrual of Latinos, it is first necessary to examine physicians’ attitudes and practices regarding these studies and factors th... Read More»

Amelie G. Ramirez, Patricia Chalela, Lucina Suarez, Edgar Muñoz, Brad H. Pollock, Steven D. Weitman and Kipling J. Gallion

Research Article: J Community Med Health Edu 2012, 2:173

DOI: 10.4172/2161-0711.1000173

Abstract Peer-reviewed Full Article Peer-reviewed Article PDF Mobile Full Article